Cargando…
Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956572/ https://www.ncbi.nlm.nih.gov/pubmed/31956629 http://dx.doi.org/10.4103/sajc.sajc_364_19 |
_version_ | 1783487173594447872 |
---|---|
author | Talreja, Vikas T. Noronha, Vanita Patil, Vijay M. Joshi, Amit Prabhash, Kumar |
author_facet | Talreja, Vikas T. Noronha, Vanita Patil, Vijay M. Joshi, Amit Prabhash, Kumar |
author_sort | Talreja, Vikas T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6956572 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-69565722020-01-17 Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience Talreja, Vikas T. Noronha, Vanita Patil, Vijay M. Joshi, Amit Prabhash, Kumar South Asian J Cancer Letter to the Editor Wolters Kluwer - Medknow 2020 /pmc/articles/PMC6956572/ /pubmed/31956629 http://dx.doi.org/10.4103/sajc.sajc_364_19 Text en Copyright: © 2019 The South Asian Journal of Cancer http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Letter to the Editor Talreja, Vikas T. Noronha, Vanita Patil, Vijay M. Joshi, Amit Prabhash, Kumar Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title | Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title_full | Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title_fullStr | Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title_full_unstemmed | Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title_short | Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience |
title_sort | lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: indian experience |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956572/ https://www.ncbi.nlm.nih.gov/pubmed/31956629 http://dx.doi.org/10.4103/sajc.sajc_364_19 |
work_keys_str_mv | AT talrejavikast lorlatinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT noronhavanita lorlatinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT patilvijaym lorlatinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT joshiamit lorlatinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience AT prabhashkumar lorlatinibinanaplasticlymphomakinasepositivenonsmallcelllungcancerindianexperience |